Staphylococcus aureus is a virulent pathogen which is responsible for a number of disease syndromes in humans and animals. It secretes a large number of proteins, several of which are known to be virulence factors while the biological role of others remains unidentified. One of the latter is phosphatidylinositol (PI)-specific phospholipase C (PI-PLC), which can affect eukaryotic cell function as a result of its ability to degrade membrane-associated inositol phospholipids. Thus, PI-PLC has been shown to mimic or interfere with cellular signalling processes (41, 48, 49, 52, 56) and to release glycosyl PI (GPI)-anchored cell surface proteins (25, 26) . However, in spite of these dramatic effects on mammalian cells, the potential contribution of PI-PLC to the initiation and persistence of staphylococcal infection has received little attention.
PI-PLC activity was first identified in S. aureus culture supernatants over 30 years ago (8, 32) . Although it was not thoroughly characterized, the early studies did suggest that the PI-PLC activity was restricted to coagulase-positive strains of staphylococci and involved in staphylococcal pathogenesis. This possibility received some support when PI-PLC activity was detected in preparations of staphylococcal delta-hemolysin (3, 62, 63) . However, independent purification of the staphylococcal PI-PLC revealed it to be devoid of hemolytic activity and demonstrated that these two activities were in fact due to distinct proteins (29) . Furthermore, subsequent studies with delta-hemolysin and other well-characterized staphylococcal toxins revealed that many contained traces of PI-PLC activity, but the low specific activity indicated contamination rather than molecular identity (28) .
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Previous work has not demonstrated a cytotoxic role for the staphylococcal PI-PLC. A metabolic or nutritional function seems unlikely because staphylococci are not reported to contain inositol phospholipids or to require free inositol for growth. A role in the salvage of fatty acids (as a carbon source) or phosphate appears equally unlikely because S. aureus produces two other enzymes, a glycerol ester hydrolase (lipase) and a sphingomyelinase (beta-hemolysin), which would give the bacterium access to much greater amounts of these nutritional components in most natural environments. In Bacillus cereus there is evidence suggesting that sphingomyelinase but not PI-PLC is involved in phosphate retrieval (15, 57) ; however, similar experiments have not been performed with S. aureus.
Previous studies have shown that staphylococcal PI-PLC is unable to lyse erythrocytes, consistent with the apparent inaccessibility of its known substrate, PI at the cell surface (29) . This is in sharp contrast to the powerful hemolytic action of two other phospholipases, Clostridium perfringens alpha-toxin and S. aureus beta-hemolysin, the substrates of which (phosphatidylcholine [PC] and sphingomyelin, respectively) are relatively abundant in the cell surface (57) . However, in the last decade there have been major advances in our understanding of the diverse and important roles that inositol phospholipids play in mammalian cell function, and a reevaluation of the potential contribution of PI-PLC to staphylococcal pathogenesis is warranted.
Marques et al. have compared the production of PI-PLC by strains of S. aureus isolated from patients with or without toxic shock syndrome or from healthy carriers (34) . Although none of the strains from healthy carriers produced PI-PLC, it was produced by 10 of the 32 pathogenic strains. There was no correlation between the production of PI-PLC and the occurrence of toxic shock syndrome, but there was a significant association between PI-PLC production and the development of acute respiratory distress syndrome (four of four patients) or disseminated intravascular coagulation (four of five patients) as complications of staphylococcal infection (34) . Although these findings are highly suggestive of a role for PI-PLC in the pathogenesis of particular staphylococcal disease syndromes, they offer no clues as to the mechanism. Furthermore, our ignorance of the genetic and environmental factors which regulate PI-PLC production in vivo and in vitro hampers a precise interpretation of such studies.
In this paper we report the cloning, characterization, and in vitro mutagenesis of the gene encoding the staphylococcal PI-PLC. We have used the cloned gene to study the expression of PI-PLC by clinical isolates of S. aureus as well as its regulation by the accessory gene regulator (agr) which controls the transcription of the several toxins and virulence factors (43) . Availability of the cloned gene will facilitate future studies of the contribution of PI-PLC to pathogenesis. (20) .
MATERIALS AND METHODS

Materials. [3H]inositol-labelled PI ([3H
Polyclonal antibodies against purified S. aureus PI-PLC (500 to 600 ,ug per injection suspended in incomplete Freund's adjuvant) were raised in two New Zealand White rabbits by two intradermal injections separated by a 2-week interval followed by repetitive subcutaneous injection at monthly intervals. The rabbits were bled at monthly intervals 6 weeks after the first injection. After the third subcutaneous injection the amount of antigen was reduced in stages to 10 ,ug per injection, allowing maintenance of high antibody titer for over 18 months. Although these antibodies reacted well in immunoblots with the purified staphylococcal PI-PLC (with only weak reactivity against the Bacillus thuringiensis PI-PLC), they also reacted with several unidentified components in staphylococcal culture supernatants. Initially it was thought that this was due to the presence of protein A released from the bacteria. However, when F(ab)2 fragments were prepared by pepsin digestion of the immunoglobulin G fraction, the problem of cross-reactivity was not substantially improved. This suggested that the initial purified antigen preparation contained trace amounts of highly immunogenic contaminants.
Bacterial strains, plasmids, phages, and culture conditions.
The Newman strain of S. aureus (originally obtained from John Pearce, Department of Microbiology, University of Birmingham, Birmingham, United Kingdom) previously used for purification of PI-PLC (29, 30) was used to isolate the gene encoding PI-PLC. This strain has been screened occasionally for colonies which produce high levels of PI-PLC in broth culture but has been otherwise free from selective pressure. S. aureus RN6112 and RN4256 are interrupted at the agr locus by a transposon insertion (TnSSJ carrying an erythromycin resistance gene) but are otherwise identical to their parental strains, RN6390 and RN4282, respectively, and were a gift from Richard P. Novick (38, 43) . and hybridized with two 32P-labelled synthetic oligonucleotides (17-mers with 64-and 48-fold degeneracy) whose sequences were based on two internal peptide sequences (DDAKYY and IQWADN) derived from purified S. aureus PI-PLC. A 6.6-kb fragment hybridizing to the probes was purified from the agarose gel with US Bioclean (USB, Cleveland, Ohio) and ligated to XbaI-EcoRI-digested XZAP. XZAP was packaged and infected into E. coli according to the supplier's instructions, and plaques were lifted onto nitrocellulose filters. Replica filters were screened with the oligonucleotide probes. Positive plaques were replated and screened with polyclonal rabbit antibodies specific for purified PI-PLC. To verify that the antibody binding by positive plaques was due to expression of PI-PLC, several plaques were analyzed for their ability to produce enzyme activity. Positive phage were grown in liquid culture, and the plasmid vector pBluescript was rescued from XZAP by using a helper phage as recommended by the supplier. E. coli XL1-Blue transformed with the recombinant plasmids was inoculated to a 100-fold dilution of an overnight culture in Luria broth supplemented with tetracycline (12.5 ug/ml) and ampicillin (50 ug/rml) and grown for 6 h with or without 10 mM isopropyl-3-D-thiogalactopyranoside (IPTG). Cell pellets from 0.5 ml of culture were resuspended in 0.11 ml of 0.4% sodium deoxycholate, and PI-PLC activity was assayed as described below. One of the plasmids (pSF122) which gave the highest expression of PI-PLC activity was used to determine the nucleotide sequence of the cloned gene.
We have designated the S. aureus gene encoding PI-PLC production plc. This designation is consistent with the nomenclature recently proposed (40) for Listeria monocytogenes genes encoding PI-PLC (plcA) and PC degrading PLC (plcB). However, a suffix letter was not deemed necessary for the staphylococcal PI-PLC gene because the sphingomyelinase (or beta-hemolysin) has already been designated hlb and there are no previous reports of PC-degrading PLC being produced by S. aureus, an observation that has been confirmed in the present study.
Restriction fragmentation and sequence analysis of pSF122 demonstrated that the insert was only 1.4 kb, suggesting that the majority of the original 6.6-kb EcoRIXbaI fragment was lost during rescue of the plasmid. To facilitate recombination into chromosomal DNA and preparation of plc mutants of S. aureus, a 9-kb XbaI fragment of S. aureus Newman DNA was cloned directly into XbaIdigested pUC19. Colony blots of transformed E. coli DH5a were screened by oligonucleotide hybridization and by immunoblotting. PI-PLC production was confirmed by enzyme assay. Several recombinant plasmids were analyzed by restriction mapping and found to be identical, containing 8 kb of sequence upstream and 0.4 kb downstream ofplc (Fig.  1) . The plc gene in one recombinant, pSF3152, was inactivated in vitro by insertion of a tetracycline resistance gene (tmn) which can be expressed in E. coli. A 3.1-kb SmaIPvuII fragment of pRN6680 containing tmn was ligated into pSF3152 linearized with EcoRV. The DNA was transformed into E. coli DH5a with selection for tetracycline (5 ,ug/ml) resistance. The tetracycline-resistant colonies were blotted to nitrocellulose filters and screened with an oligonucleotide probe for plc. Positive clones were analyzed by restriction fragmentation and Southern blot analysis and the ability to produce PI-PLC activity.
Purification of PI-PLC. PI-PLC was purified from culture supernatants of S. aureus Newman or B. subtilis BG2320 transformed with a plasmid (pMY15) containing theplc gene from B. thunngiensis as described previously (27, 30) . Apart from the initial culture and the preparation of the cell lysate, the PI-PLC from E. coli transformed with pSF122 was purified by the same procedure. Four 2-liter Erlenmeyer flasks containing 500 ml of Luria broth (50 ,ug of ampicillin per ml) were inoculated with 5-ml aliquots of an overnight culture grown in the same media. The flasks were incubated in an orbital shaker (250 rpm) for 20 h at 37°C. The bacteria were harvested by centrifugation and resuspended in 400 ml of 100 mM NaCl-1 mM EDTA-50 mM Tris-HCl, pH 8 (buffer A), containing 0.1 mg of lysozyme per ml and 0.5 mM phenylmethylsulfonyl fluoride. The cell suspension was stirred at ambient temperature for 60 min, 80 ml of 1% Triton X-100 in buffer A was added, and stirring was continued for an additional 30 min. Subsequent steps were performed at 0 to 4°C. The lysed cell suspension was then centrifuged at 15 ,000 x g for 30 min. The viscous supernatant was adjusted to pH 5.3 with acetic acid, filtered through two layers of Miracloth (Calbiochem), and frozen at -20°C overnight. The thawed supernatant was refiltered with Whatman no. 1 filter paper and applied (100 ml/h) to a column (2.5 by 10 cm) of Amberlite CG-50 resin equilibrated with 150 mM NaCi-50 mM Na acetate-NaOH, pH 5.3 (buffer B). The column was washed with 300 ml of buffer B and eluted with a linear gradient consisting of 250 ml each of buffer B and 1 M trisodium citrate. The active fractions were identified by PI-PLC assay, pooled, and concentrated to 15 ml with a stirred Amicon ultrafiltration cell with a YM10 membrane. The concentrate was dialyzed overnight versus 500 ml of 50 mM Tris acetate-0.02% sodium azide, pH 7.4 (buffer C). The dialysate was adjusted to pH 7.4 with 1 M Tris-OH and centrifuged at 15,000 x g for 30 min. The combined supernatants from several batches were further purified by chromatography on Sephadex G-75 and Mono S (27, 30) . The purified protein was analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and quantified by the bicinchoninic acid protein assay (30) . Approximately 1.5 mg of PI-PLC was purified from a total of 5 liters of bacterial culture.
PI-PLC assay. PI-PLC and PC-PLC activities were determined as described previously (27, 30 (53) .
DNA sequence analysis. Nucleotide sequences were determined in both directions with the Sequenase 2.0 DNA sequencing kit (USB). The primers used were the degenerate oligonucleotides based on peptide sequence (described above), exact oligonucleotides based on determined nucleic acid sequence (synthesized by the Protein Chemistry Core Facility of Columbia University), or universal primers (T3 and 1T7) purchased from Stratagene. DNA sequences were analyzed by using the Genetics Computer Group (version 7) software package. Sequence similarity between pairs of bacterial PI-PLCs was determined by using the BESTFIT program, and multiple sequences were aligned by using PILEUP. The sequence of the staphylococcal plc gene was also compared against the GenBank bacterial data base (release 75.0).
Nudeotide sequence accession number. The nucleotide sequence reported in this paper has been submitted to GenBank and assigned the accession number L19298.
RESULTS
Cloning, subcloning, and in vitro mutagenesis of the pie gene. E. coli XL1-Blue transformed with rescued phagemid (that screened positive with the oligonucleotide probes and anti-PI-PLC antibodies) was shown to produce PI-PLC activity (Table 1) . By contrast, bacteria transformed with pBluescript alone expressed no activity. Addition of IPTG to the cultures had no effect on the amount of PI-PLC produced (data not shown), indicating that the cloned gene contained all of the necessary regulatory elements. It was subsequently determined that theplc gene was in the opposite orientation of the lac operon of pBluescript. One recombinant, pSF122, containing a 1.4-kb insert ( Fig. 1) was used for sequencing of the plc gene and for purification of PI-PLC (see below).
To facilitate recombination into chromosomal DNA and preparation ofplc mutants of S. aureus, a 9-kb fragment of S. aureus Newman DNA, encoding PI-PLC, was cloned directly into pUC19 to generate pSF3152. The staphylococcal tetracycline resistance gene, tmn, was inserted into the EcoRV site of pSF3152 and transformed into E. coli DH5a (Fig. 1) . Southern blotting of two tetracycline-resistant mutants (SF5201 and SF5205) showed that the XbaI restriction fragment which containedplc had increased in size from 9 to 12 kb, consistent with the insertion of tmn. This was confirmed by loss of the ability to express PI-PLC activity (Table 1) , by Southern blotting with tmn as a probe, and by sequencing (data not shown).
Nucleotide and amino acid sequence ofple. The nucleotide sequence of the plc gene on pSF122 was determined and found to consist of 984 bp (Fig. 2a) . This sequence predicts an open reading frame of 327 amino acid residues which contains the two 28-residue peptide sequences determined from the purified PI-PLC isolated from S. aureus Newman (residues 109 to 136 and 194 to 221; not indicated in figure) . The S. aureus PI-PLC sequence was compared with sequences in the GenBank data base, but apart from the PI-PLCs from B. thuringiensis (17) , B. cereus (22) , and L. sphingomyelin-specific PLC, (42, 57, 62) , revealed only 20% identity (40% similarity). The GPI-PLC from the parasitic protozoan T. brucei is related to the bacterial PI-PLCs by several criteria that are not shared by other eukaryotic PLCs which degrade inositol phospholipids: the ability to hydrolyze GPI, a similar molecular mass (41 kDa), and an absence of a divalent metal ion requirement (for references, see references 18 and 47).
Comparison of the S. aureus and T. brucei sequences indicated that they were 22% identical (44% similar). When the bacterial PI-PLC sequences are compared, there are four short regions of 7 to 10 residues in which there is a 75% or greater similarity. One of these sequences, GXRXXDXR (where X represents amino acids with aromatic or relatively hydrophobic aliphatic side chains; Fig. 2b ), is of par icular interest since it exhibits an equal degree of conservation in the T. brucei GPI-PLC, suggesting that it may participate in substrate binding and/or catalysis. This sequence is not present in the staphylococcal beta-hemolysin.
Characterization of staphylococcal PI-PLC expressed in E. coli. (i) Molecular mass. As described above, E. coli transformed with pSF122 expressed PI-PLC activity and the yield (approximately 20 mU/ml of culture) was sufficient for purification and biochemical characterization. The molecular weights of the recombinant and the Newman PI-PLCs were indistinguishable by SDS-polyacrylamide gel electrophoresis. However, the mobility of the S. aureus PI-PLC is slightly greater than that obtained for B. thuringiensis PI-PLC (Fig. 3) , which suggests that it has a slightly lower molecular mass (32 versus 33.3 kDa) . A similar difference of 1 to 2 kDa was obtained in a previous study comparing the S. aureus and B. thuringiensis PI-PLCs (30) . The N-terminal sequences were determined to be XXSLSKSPEN (where X equals unidentified residues) and SDSLSKS for the Newman-and pSF122-derived PI-PLCs, respectively. This indicates that in both E. coli and S. aureus a 26-residue peptide was removed from the amino terminus, producing a 301-residue peptide with a calculated molecular mass of 34,107 Da (compared to 34,511 Da for B. thuringiensis). The signal peptide exhibits many of the features typically found at the N termini of secreted proteins: a positively charged aminoterminal region, a relatively hydrophobic core of 9 residues, and alanine residues at the -3 and -1 sites (61). [3H]VSG degradation were identified as inositol 1,2-cyclic phosphate and diacylglycerol, respectively, as expected for a PLC (data not shown).
In a previous study it was noted that the specific activity of the B. thuringiensis PI-PLC was substantially greater than that of the PI-PLC purified from the Newman strain of S. aureus (30) . A similar result was obtained in the present study, in which specific activity (using [3H]PI as a substrate) for S. aureus PI-PLC derived from both the Newman strain and pSF122 was less than 10% of that observed for the B. thuringiensis PI-PLC derived from pMY15 (Table 2) . By contrast, activity towards VSG was only about 40% of that exhibited by B. thuingiensis PI-PLC ( Table 2 ). The reason for these differences in specific activity is unknown, but their occurrence in both the wild-type and recombinant PI-PLCs indicates that they are an intrinsic feature of the enzyme. Differences in specific activity for PI and VSG were noted in a previous study when PI-PLCs from L. monocytogenes and B. thunrngiensis were compared (13) .
(iii) Effect of pH. Previous studies by Doery et al. using crude S. aureus PI-PLC suggested that it had a pH optimum of 4.5 (8). It was not possible to confirm this result with the purified PI-PLC by our standard assay procedure because the detergent used for suspending the substrate (sodium deoxycholate) precipitates below pH 7. This problem was avoided by performing the assay in 0.01% Triton X-100. for PI-PLCs from B. thuringiensis (Bt) (17) and L. monocytogenes (Lm) (35) and for GPI-PLC from the protozoan T. brucei (Tb) (18) . The NH2 terminus of the mature polypeptide from S. aureus is indicated by an arrowhead. Isolated identical residues and regions of similarity are indicated by circles and underlining, respectively. Indicators of identity and similarity appear below the sequences when they apply only to the bacterial PI-PLCs but also appear above if they apply to all four PLCs. The amino acid sequence of B. cereus PI-PLC (22) is 98% identical to that reported for B. thuringiensis and is not shown. None of the residues which differ between the two Bacillus sequences are located in regions of identity or similarity identified in the figure. Degradation of PI by either the S. aureus or B. thuringiensis PI-PLC exhibited a pH optimum of approximately 5.5 to 6.0 (Fig. 4) . Activation of the S. aureus PI-PLC at low pH was particularly pronounced, with an approximately 20-fold increase in activity between pH 7.5 and 5.5. Similar results were obtained using VSG as a substrate, although the pH optimum was approximately 5.0. Increased PI and VSG degradation at low pH was observed with both HEPESmorpholineethanesulfonic acid (MES)-NaOH buffers (Fig. 4) and HEPES-acetate-NaOH buffers (data not shown).
(iv) Inhibition by NaCl. One property of the native S. aureus PI-PLC already known to distinguish it from other bacterial PI-PLCs is its extreme sensitivity to inhibition by salt solutions (30) . The PI-PLCs from pSF122 and Newman exhibited identical sensitivity to NaCl inhibition (50% inhibitory concentration of 10 to 20 mM) with either PI or VSG suspended in Triton X-100 as a substrate (data not shown). By contrast, the PI-PLC from B. thunrngiensis was relatively insensitive and required approximately 75 mM NaCl to give 50% inhibition of PI degradation and actually stimulated VSG degradation up to 150 mM NaCl. Inhibition by NaCl was also obtained with substrates suspended in sodium deoxycholate, although the effects were less pronounced (data not shown). [3H]PI suspended in Triton X-100 (0.01% final concentration) was incubated with S. aureus PI-PLC purified from E. coli transformed with pSF122 (66 ng; 0) or B. thuringiensis PI-PLC (0.9 ng; *) at the pH indicated (100 mM HEPES-MES-NaOH buffer). At (v) Inhibition by thiol reagents. Previous studies of the PI-PLC from S. aureus had indicated that it was sensitive to inhibition by the thiol-reactive agents HgCl2, CUS04, and p-chloromercuribenzoate, suggesting that a cysteine residue might be located in or near the active site (29) . However, this possibility was eliminated by the observation that the predicted sequence did not contain any cysteine residues (Fig.  2b) . We therefore reevaluated this question using a variety of thiol-reactive reagents assayed under different conditions. Pretreatment with the alkylating agents sodium iodoacetate and N-ethylmaleimide (2.5 mM, 60 min, 0°C; data not shown) did not produce significant inhibition of PI degradation by S. aureus PI-PLC (from pSF122). Some inhibition was observed with iodoacetate (but not N-ethylmaleimide) if the treatment was carried out at 37°C for 30 min, but this amounted to a maximum of only 20 to 30%. B. thunngiensis PI-PLC was not inhibited by either of these reagents (data not shown).
In contrast, both the S. aureus and the B. thunngiensis PI-PLCs were sensitive to inhibition by HgCl2 (50% inhibitory concentration, -5 to 10 ,uM) and Cu2SO4 (50% inhibitory concentration, -5 ,M for S. aureus and -1 ,uM for B. thuringiensis). Inhibition of PI degradation by these metal ions was similar whether Triton X-100 or deoxycholate was used to suspend the substrate. Inhibition (60 to 90%) was also observed with 0.25 mM p-chloromercuriphenylsulfonate. The response to these inhibitors was identical when the two S. aureus PI-PLC preparations were compared with each other.
The mechanism of the potent inhibition by heavy metal ions is unclear. The concentrations required were so low (< 10 ,uM) that inhibition is unlikely to have resulted from an effect on substrate presentation due to an interaction between the metal ion and the substrate (100 p,M). We propose that inhibition results instead from a direct binding of the metal ion to the PI-PLC via a side-chain group other than cysteine. It is likely that a similar mechanism is responsible for the inhibition of the B. thuringiensis PI-PLC because it also is devoid of cysteine residues (Fig. 2b) (14) . A cysteineindependent mechanism has been proposed previously for the inhibition of bovine brain PLC--y by micromolar concentrations of Hg2+, Cu2+, Cd2+, and Zn2+ (51). (Fig. 5) . Analysis of the culture supematants by Western blotting (immunoblotting) with a polyclonal antibody against PI-PLC confirmed that mutation of the agr locus reduced the amount of PI-PLC produced (data not shown). However, it is also apparent from Fig. 5 that production of PI-PLC by both the agr mutant and the agr+ strain was increased three-to sixfold by culturing in THB rather than CY medium. This result suggested that PI-PLC production can be regulated by both agr-dependent and agr-independent mechanisms. Analysis of the DNA from these strains by Southern blotting indicated that theplc locus was identical in both strains and therefore the reduction in PI-PLC activity was not caused by a change in plc itself (Fig. 6a, lanes 3 and 4) . In the amount of PI-PLC activity compared with that of its wild-type parent, RN4282 (data not shown). The amount of PI-PLC produced by these strains was also sensitive to the type of medium and increased severalfold when cultured in THB rather than CY medium. However, when analyzed by Southern blotting, the plc locus of the parent, RN4282 (Fig.  6a, lane 1) , showed a restriction pattern different from that of the mutant RN4256 (Fig. 6a, lane 2) as well as those of RN6390 and RN6112 (Fig. 6a, lanes 3 and 4) and the Newman strain (Fig. 6c, lane 1) . Therefore, although the reduced amount of PI-PLC in RN4256 is most likely due to the inactivation of agr, this result must be interpreted with caution since theplc locus in the mutant is not identical to 4 5 6 7 8 9 9.4 -6.6-few 4-4 -that of its parent. We also attempted to determine whether the reduced PI-PLC secretion resulted from a decrease inplc transcription. However, mRNA encoding PI-PLC was not detectable by Northern blotting in any of these strains (data not shown), and consequently we were unable to confirm that regulation of PI-PLC levels in the culture medium occurred at the transcriptional level. The inability to detect mRNA is consistent with the low level of PI-PLC produced as described below for other S. aureus strains.
PI-PLC production by clinical isolates and other Staphylococcus species. Preliminary studies of different strains of S. aureus had indicated that most produced very little PI-PLC (7). However, the ability of these strains to produce PI-PLC might have been lost during subculture and storage. To address this issue, fresh clinical isolates of S. aureus were cultured and the amount of PI-PLC in the supernatant was determined by enzyme assay (Fig. 7) . Although all the culture supernatants contained detectable PI-PLC activity there was an -30-fold range in the amount produced. When these analyses were repeated several months later using frozen stock cultures, most of the strains produced substantially less PI-PLC (data not shown). The maximum amount of PI-PLC produced by the isolates (e.g., C240) was 10 to 20 mU ml-1 compared to the 100 to 200 mU ml-1 produced by the Newman strain. The culture supernatants were also analyzed by Western blotting with F(ab)2 fragments of a polyclonal antibody raised against purified PI-PLC. Interpretation of these analyses was complicated by cross-reactivity with other proteins in the culture supernatants. In spite of this, the strength of the signal (i.e., a band with mobility similar to that of the purified PI-PLC) correlated reasonably well with the amount of PI-PLC produced (data not shown). mRNA extracted from 6-h cultures of the Newman strain and several of the clinical isolates was visualized by Northern blotting using the HindIII fragment of pSF122 as a probe. A band of approximately 1 kb was observed in the Newman strain but not in C240, C400, or C389 (data not shown). However, in one RNA preparation a faint 1-kb band was observed with C240. The absence of a positive signal in the Northern blot is consistent with the relatively low levels of PI-PLC produced by the clinical isolates compared with those produced by the Newman strain (Fig. 7) . (Fig. 6b) , all 10 isolates gave a positive signal under conditions of high stringency, suggesting that they possess a plc gene. However, in four of the strains (C325, C270, C389, and C229) the HindIII restriction fragment containing plc was substantially larger (approximately 6.1, 6.8, or 18 kb) than that observed in the Newman strain (approximately 2.7 kb). The DNA in each isolate was also digested at a site within the plc gene with SnaBI (Fig.  6c) . As expected, Newman gave two fragments of approximately 1.9 and 3.4 kb. However, among the clinical isolates only C240 gave these two fragments (Fig. 6c) . In all the other isolates the probe hybridized to only one fragment of approximately 2.8 (C400 and C323), 4.6 (C490, C367, and C360), 6 .9 (C325), 8.6 (C270 and C389), or 15 (C229) kb.
Several of the other bacterial species which are known to produce PI-PLC also secrete a PLC which can hydrolyze PC (PC-PLC). However, there is no recent information concerning the presence of such an enzyme in culture supernatants of S. aureus. We therefore tested the supernatants from the clinical isolates and the Newman strain for their ability to degrade [3H]PC. One of the isolates (C240) produced detectable PC-degrading activity (0.032 mU ml-1), but this was <1% of that exhibited when PI was used as a substrate. Preincubation of this culture supernatant with 2.5 mM phenanthroline resulted in approximately 40% inhibition of the PC-degrading activity, suggesting that it might be a PC-PLC (24) , but the activity was too low for this to be confirmed by product analysis. The other strains did not produce detectable PC-PLC activity (<0.006 mU ml-1).
To determine whether the ability to produce PI-PLC was restricted to S. aureus, other staphylococcal species were studied. Culture supernatants of clinical isolates of S. epidermidis (a total of five), S. hominis, and Staphylococcus simulans were tested, but none of them produced detectable PI-PLC activity. Culture supernatants from standard strains of S. epidermidis (ATCC 155 and ATCC 14990), S. hominis (ATCC 29885), S. saprophyticus (ATCC 15305), S. sciun (ATCC 29060), and S. xylosus (ATCC 29971) were analyzed also, but no PI-PLC activity could be detected (<0.1 mU/ml; data not shown). HindlIl restriction digests of all 13 of these staphylococcal strains were analyzed by Southern blotting using the plc probe, but none gave a positive signal (representative data from an S. epidennidis strain, C572, is shown in Fig. 6b and 7) .
DISCUSSION
A survey of S. aureus isolates from patients with staphylococcal infections showed that approximately 30% produced detectable levels of PI-PLC activity when cultured in vitro whereas S. aureus isolated from healthy volunteers did not produce PI-PLC (34) . Although this correlation is suggestive of a role for PI-PLC in pathogenesis, there were large variations among the positive strains in the absolute amounts of activity produced. The present study also revealed large variations in PI-PLC production between different isolates when cultured in vitro. In addition, we have previously noticed that PI-PLC production was extremely sensitive to the culture conditions and that the different isolates did not respond uniformly to these variations in the culture conditions (7) . These findings make it difficult to extrapolate the results of in vitro studies to the situation in vivo and raise doubts about the significance of any correlations (either positive or negative) between PI-PLC production and staphylococcal disease syndromes. For example, low levels of PI-PLC production could reflect altered sensitivity to multiple and as yet poorly defined regulatory factors or to alterations in the gene encoding PI-PLC. Clearly the contribution of regulatory factors (identified in vitro) to overall PI-PLC production could assume greater or lesser relative importance in vivo.
To gain a better understanding of the regulation of PI-PLC production by S. aureus and its possible role in virulence, we have cloned the plc gene. This has allowed us to make a preliminary evaluation of the relative contribution of strain variations which affect the plc gene as opposed to those which might be affecting regulatory genes. Southern blotting of HindIII fragments from clinical isolates of S. aureus indicated that they all possess a plc gene. This result contrasts sharply with that obtained with six other staphylococcal species (a total of 13 strains) for which no evidence for aplc gene could be obtained either by enzyme assay of culture supernatants or by Southern blotting. These strains represent four of the six groups of coagulase-negative staphylococcal species delineated by DNA-DNA hybridization studies (21) , and this result suggests that S. aureus is the only species in this genus which expresses PI-PLC. The The production of many extracellular proteins by S. aureus has been shown to depend on the action of a common regulatory locus, agr (43) . It was therefore of interest to determine whether the production of PI-PLC was regulated in a similar fashion. In an isogenic pair of S. aureus strains the agr mutant strain secreted substantially less PI-PLC than the agr+ strain. The agr locus is known to act as a transcriptional regulator, but we were unable to study this because mRNA encoding PI-PLC could not be detected in either of these strains, presumably because of the low level produced. Although our results indicate that the agr locus may play an important role in the regulation of PI-PLC production, it is likely that other factors are involved also. For example, the dependence of PI-PLC production on the type of medium was similar in both the agr+ and agr mutant strains, suggesting that the agr locus was not required for the response to this particular set of environmental conditions. Previous studies have demonstrated both agr-dependent and agrindependent regulation of staphylococcal enterotoxin C production by environmental stimuli (44) (45) (46) , and the large increases in PI-PLC production observed when S. aureus was grown in glucose-free media at low pH (33) suggest agr-independent regulation. Consistent with these observations is the recent localization of two pleiotropic mutations, xpr (55) and sar (6) , which affect extracellular protein production, to chromosomal sites distinct from that of agr. The isolation of the plc gene will undoubtedly facilitate a more detailed evaluation of environmental and genetic factors governing PI-PLC production by S. aureus.
One additional factor which might contribute to the variable amount of PI-degrading activity detected in the culture supernatants prepared from the clinical isolates is the production of a distinct phospholipase that was also capable of hydrolyzing PI. The other bacteria which are known to produce PI-PLC also produce a PLC (PC-PLC) with relatively broad substrate specificity which hydrolyzes PC, phosphatidylethanolamine, and phosphatidylserine. Although the ability of this PLC to act on PI was in doubt (11, 24, 57) , recent work indicates that the PC-PLCs from L. monocytogenes and B. cereus do in fact have weak activity against PI (12) . S. aureus was reported to produce a phospholipase A activity which acted on PC (8, 32), but we are not aware of any recent studies in which culture supernatants have been analyzed for PC-PLC by sensitive assays with radiolabelled substrates. It was therefore a reasonable possibility that the low PI-degrading activity which we detected with some strains of S. aureus reflected production of such a PC-PLC. However, our analyses indicate that none of the S. aureus strains which exhibit low PI-degrading activity express PC-PLC. Although we cannot exclude the production by S. aureus of two distinct PI-degrading activities, the available evidence suggests that it is unlikely.
Marques et al. (33) have reported that recovery of PI-PLC activity from S. aureus is markedly enhanced after culture at acidic pH, and they have suggested that this may enhance the contribution of PI-PLC to pathogenesis in abscesses in which the extracellular pH is low. The present studies with the purified enzyme reveal an additional mechanism whereby an acidic environment might enhance the pathogenic contribution of PI-PLC, namely, increased catalytic activity. Acidic environments are also found in phagocytic compartments inside cells, and even though S. aureus is not regarded as an intracellular pathogen, it has been reported to persist inside phagocytes or endothelial cells for prolonged periods after uptake (1, 2, 16, 19, 31, 58) . Substrates in the lumen of a phagolysosome containing S. aureus would be highly susceptible to degradation by PI-PLC because of the close proximity, increased catalytic activity, and increased secretion rate favored by such an environment.
The gram-positive bacteria (i.e., S. aureus, Bacillus anthracis, B. cereus, B. thuringiensis, Clostridium novyi, and L. monocytogenes) which produce PI-PLC are all opportunistic pathogens but differ widely in the types of disease they cause, and consequently it is difficult to envisage PI-PLC playing a similar role in the pathogenic process for each of them. Even so, there is some evidence suggesting that PI-PLC contributes to pathogenesis. For example, studies with S. aureus have indicated a correlation between pathogenesis and the ability to produce PI-PLC (34) . Furthermore, the present and previous studies indicate that the less pathogenic species of Staphylococcus (this paper) and Listeria (37) are unable to produce PI-PLC. Studies of virulence in a delta-endotoxin-deficient strain of the insect pathogen B. thuringiensis have indicated that production of both the PI-PLC and the PC-PLC is decreased in a spontaneous mutant which is unable to infect insect larvae (64) . Finally, site-directed plc mutants of L. monocytogenes exhibit reduced ability to escape from the phagolysosome after being phagocytosed by macrophages, thereby inhibiting the spread of infection from cell to cell (5, 40) . While there are no obvious similarities between the pathogenic mechanisms utilized by S. aureus, L. monocytogenes, and B. thunngiensis, this may simply reflect the fact that there are numerous potential targets for PI-PLC on or in eukaryotic cells. Inositol phospholipids not only are involved in eukaryotic signal transduction processes (47) but also are responsible for membrane anchoring of a large number of cell surface proteins (25) . Either of these important functions could be severely compromised by the action of an exogenous bacterial PI-PLC. It is obviously premature to speculate about the identity of molecules in mammalian cells which might be targets for PI-PLC action during a staphylococcal infection. However, loss of important cell surface molecules (25, 26) , altered responsiveness to extracellular signals (41, 48, 49, 52, 56) , and breakdown of intracellular pools of inositol phospholipids (9) have all been observed in vitro and merit serious consideration.
